Gene expression profiling of skeletal muscles treated with a soluble activin type IIB receptor
about
Fam65b is important for formation of the HDAC6-dysferlin protein complex during myogenic cell differentiationBlockade of ActRIIB signaling triggers muscle fatigability and metabolic myopathy.Muscle wasting and the temporal gene expression pattern in a novel rat intensive care unit model.Mammalian Mss51 is a skeletal muscle-specific gene modulating cellular metabolism.Increasing muscle mass to improve metabolism.Systemic blockade of ACVR2B ligands prevents chemotherapy-induced muscle wasting by restoring muscle protein synthesis without affecting oxidative capacity or atrogenes.New function of the myostatin/activin type I receptor (ALK4) as a mediator of muscle atrophy and muscle regeneration.Myostatin deficiency but not anti-myostatin blockade induces marked proteomic changes in mouse skeletal muscle.IGFN1_v1 is required for myoblast fusion and differentiation.Mitochondrial impairment induced by postnatal ActRIIB blockade does not alter function and energy status in exercising mouse glycolytic muscle in vivo.Combined Strategies for Maintaining Skeletal Muscle Mass and Function in Aging: Myostatin Inactivation and AICAR-Associated Oxidative Metabolism Induction.Muscle protein synthesis, mTORC1/MAPK/Hippo signaling, and capillary density are altered by blocking of myostatin and activins.Prevention of chemotherapy-induced cachexia by ACVR2B ligand blocking has different effects on heart and skeletal muscle.Exercise restores decreased physical activity levels and increases markers of autophagy and oxidative capacity in myostatin/activin-blocked mdx mice.Soluble activin receptor type IIB decoy receptor differentially impacts murine osteogenesis imperfecta muscle function.Metabolic adaptations in skeletal muscle after 84 days of bed rest with and without concurrent flywheel resistance exercise.
P2860
Q24293492-2E87DBF1-A36C-4F94-A4CB-82289F44C9B2Q30650948-A19BD072-B0F7-491F-93C7-EBC35DEF51ACQ34099711-5FA84C5B-1368-40E4-9FDE-AA24C4B3B35AQ36332477-EF19DEE4-33EE-4A1D-BDE7-7D415426019BQ36866082-335F5C58-EE36-4B2E-8943-169F5AEB277CQ37282125-B6BB9DB0-894D-4921-946C-58C11DDE130FQ37510390-9548C410-326D-4A42-9669-FEA3CFA9DD94Q38446973-996E537A-8CDA-4063-A647-238436DAF0B4Q38698550-EAB8F4AC-26CC-4701-98A1-5518FE056D29Q40030669-F4E395CD-6F33-4827-8CEC-62C0D435D88FQ44669756-F147ECA1-54B4-46CE-B3E2-696AF6A110A5Q46401273-70CB5F0F-B75C-4520-947B-7A43E478809CQ47303605-8B5736F9-9C4A-4362-BE93-C2D9650DF2B6Q50973442-100935A2-876E-4F5E-9E3A-2E1519FC8939Q52864293-89C28971-8613-4BCE-BB55-B6CABFBCD0CBQ53758425-84FDED83-DED4-4A78-891E-D38B513A2651
P2860
Gene expression profiling of skeletal muscles treated with a soluble activin type IIB receptor
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Gene expression profiling of s ...... uble activin type IIB receptor
@ast
Gene expression profiling of s ...... uble activin type IIB receptor
@en
Gene expression profiling of s ...... uble activin type IIB receptor
@nl
type
label
Gene expression profiling of s ...... uble activin type IIB receptor
@ast
Gene expression profiling of s ...... uble activin type IIB receptor
@en
Gene expression profiling of s ...... uble activin type IIB receptor
@nl
prefLabel
Gene expression profiling of s ...... uble activin type IIB receptor
@ast
Gene expression profiling of s ...... uble activin type IIB receptor
@en
Gene expression profiling of s ...... uble activin type IIB receptor
@nl
P2093
P2860
P1476
Gene expression profiling of s ...... uble activin type IIB receptor
@en
P2093
Charles P Emerson
Fedik Rahimov
Kathryn R Wagner
Leigh C Warsing
Louis M Kunkel
Oliver D King
Rachel E Powell
P2860
P304
P356
10.1152/PHYSIOLGENOMICS.00223.2010
P577
2011-01-25T00:00:00Z